TrialSignal
Clinical trial intelligence report
Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT04174586-Jul 28, 2026
NCT ID
NCT04174586
Status
UNKNOWN
Phase
PHASE1
Sponsor
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Executive brief
Investment-Ready Snapshot
Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia is a PHASE1 clinical asset sponsored by The Affiliated Hospital of the Chinese Academy of Military Medical Sciences in Safety Issues, Efficiency. SEO and diligence focus: microtransplantation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04174586
Indication
Safety Issues
Modality
protein therapy
Target
microtransplantation
Intervention
microtransplantation
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.